Literature DB >> 18331399

Melanosomal damage in normal human melanocytes induced by UVB and metal uptake--a basis for the pro-oxidant state of melanoma.

Shirley Gidanian1, Mallory Mentelle, Frank L Meyskens, Patrick J Farmer.   

Abstract

Melanins are ubiquitous catecholic pigments, formed in organelles called melanosomes within melanocytes, the function of which is to protect skin against harmful effects of UV radiation. Melanosomes within melanoma cells are characteristically abnormal, with fragmented melanin and disrupted membranes. We hypothesize that the disruption of melanosomal melanin might be an early event in the etiology and progression of melanoma, leading to increased oxidative stress and mutation. In this report, we examine the effect of a combination of UV treatment and metal ion exposure on melanosomes within melanocytes, as well as their ability to act as pro-oxidants in ex situ experiments, and assay the effects of this treatment on viability and cell cycle progression. UVB exposure causes morphologic changes of the cells and bleaching of melanosomes in normal melanocytes, both significantly enhanced in Cu(II) and Cd(II)-treated cells, as observed by microscopy. The promoted bleaching by Cu(II) is due to its ability to redox cycle under oxidative conditions, generating reactive oxygen species; verified by the observed enhancement of hydroxyl radical generation when isolated melanosomes were treated with both Cu(II) ions and UVB, as assayed by DNA clipping. Single-dose UVB/Cu treatment does not greatly affect cell viability or cell cycle progression in heavily pigmented cells, but did so in an amelanotic early stage melanoma cell line.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18331399      PMCID: PMC5746029          DOI: 10.1111/j.1751-1097.2008.00309.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  71 in total

Review 1.  The melanosome: membrane dynamics in black and white.

Authors:  M S Marks; M C Seabra
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

2.  The patterns of melanosome distribution in keratinocytes of human skin as one determining factor of skin colour.

Authors:  H-Y Thong; S-H Jee; C-C Sun; R E Boissy
Journal:  Br J Dermatol       Date:  2003-09       Impact factor: 9.302

3.  The ultrastructure of benign pigmented naevi and melanocarcinomas in man.

Authors:  R C Curran; B G McCann
Journal:  J Pathol       Date:  1976-07       Impact factor: 7.996

4.  Cytotoxic interactions of Zn2+ in vitro: melanoma cells are more susceptible than melanocytes.

Authors:  J Borovanský; M Blasko; J Siracký; A A Schothorst; N P Smit; S Pavel
Journal:  Melanoma Res       Date:  1997-12       Impact factor: 3.599

5.  Phenotypic characteristics of cells derived from precursors of human melanoma.

Authors:  M Herlyn; D Herlyn; D E Elder; E Bondi; D LaRossa; R Hamilton; H F Sears; G Balaban; D Guerry; W H Clark
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

6.  RelA, p50 and inhibitor of kappa B alpha are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B.

Authors:  S E McNulty; N B Tohidian; F L Meyskens
Journal:  Pigment Cell Res       Date:  2001-12

7.  The impact of epidermal melanin on objective measurements of human skin colour.

Authors:  Simon Alaluf; Derek Atkins; Karen Barrett; Margaret Blount; Nik Carter; Alan Heath
Journal:  Pigment Cell Res       Date:  2002-04

8.  The Tanzanian human albino skin. Natural history.

Authors:  J Luande; C I Henschke; N Mohammed
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

9.  Homozygous germline mutation of CDKN2A/p16 and glucose-6-phosphate dehydrogenase deficiency in a multiple melanoma case.

Authors:  Stan Pavel; Nico P Smit; Hans van der Meulen; Ria M Kolb; Anton J de Groot; Pieter A van der Velden; Nelleke A Gruis; Wilma Bergman
Journal:  Melanoma Res       Date:  2003-04       Impact factor: 3.599

10.  During human melanoma progression AP-1 binding pairs are altered with loss of c-Jun in vitro.

Authors:  Sun Yang; Susan McNulty; Frank L Meyskens
Journal:  Pigment Cell Res       Date:  2004-02
View more
  17 in total

1.  Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.

Authors:  John L Joyal; John A Barrett; John C Marquis; Jianqing Chen; Shawn M Hillier; Kevin P Maresca; Marie Boyd; Kenneth Gage; Sridhar Nimmagadda; James F Kronauge; Matthias Friebe; Ludger Dinkelborg; James B Stubbs; Michael G Stabin; Rob Mairs; Martin G Pomper; John W Babich
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

Review 2.  Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesis.

Authors:  Ryan W Dellinger; Feng Liu-Smith; Frank L Meyskens
Journal:  J Photochem Photobiol B       Date:  2014-06-20       Impact factor: 6.252

3.  Amyloids, melanins and oxidative stress in melanomagenesis.

Authors:  Feng Liu-Smith; Carrie Poe; Patrick J Farmer; Frank L Meyskens
Journal:  Exp Dermatol       Date:  2014-11-18       Impact factor: 3.960

4.  Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma.

Authors:  Anna A Brożyna; Wojciech Jóźwicki; J Andrew Carlson; Andrzej T Slominski
Journal:  Hum Pathol       Date:  2013-06-19       Impact factor: 3.466

5.  The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis.

Authors:  Christopher M Cabello; Sarah D Lamore; Warner B Bair; Shuxi Qiao; Sara Azimian; Jessica L Lesson; Georg T Wondrak
Journal:  Invest New Drugs       Date:  2011-05-06       Impact factor: 3.850

6.  MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1.

Authors:  Feng Liu; Yan Fu; Frank L Meyskens
Journal:  J Invest Dermatol       Date:  2008-10-30       Impact factor: 8.551

7.  Phosphorylation and subcellular localization of p27Kip1 regulated by hydrogen peroxide modulation in cancer cells.

Authors:  Irene L Ibañez; Candelaria Bracalente; Cintia Notcovich; Ivanna Tropper; Beatriz L Molinari; Lucía L Policastro; Hebe Durán
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

8.  Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin.

Authors:  Todd D Prickett; Brad Zerlanko; Jared J Gartner; Stephen C J Parker; Ken Dutton-Regester; Jimmy C Lin; Jamie K Teer; Xiaomu Wei; Jiji Jiang; Guo Chen; Michael A Davies; Jeffrey E Gershenwald; William Robinson; Steven Robinson; Nicholas K Hayward; Steven A Rosenberg; Elliott H Margulies; Yardena Samuels
Journal:  J Invest Dermatol       Date:  2013-09-05       Impact factor: 8.551

9.  Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin.

Authors:  Yoshihiko Fujita; Satoshi Koinuma; Marco A De Velasco; Jan Bolz; Yosuke Togashi; Masato Terashima; Hidetoshi Hayashi; Takuya Matsuo; Kazuto Nishio
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

10.  Apurinic/apyrimidinic endonuclease/redox effector factor-1(APE/Ref-1): a unique target for the prevention and treatment of human melanoma.

Authors:  Sun Yang; Frank L Meyskens
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.